| Title : Design, synthesis and biological evaluation of phthalimide-alkylamine derivatives as balanced multifunctional cholinesterase and monoamine oxidase-B inhibitors for the treatment of Alzheimer's disease - Sang_2017_Bioorg.Med.Chem.Lett_27_5053 |
| Author(s) : Sang Z , Wang K , Wang H , Yu L , Ma Q , Ye M , Han X , Liu W |
| Ref : Bioorganic & Medicinal Chemistry Lett , 27 :5053 , 2017 |
|
Abstract :
A series of novel phthalimide-alkylamine derivatives were synthesized and evaluated as multi-functions inhibitors for the treatment of Alzheimer's disease (AD). The results showed that compound TM-9 could be regarded as a balanced multi-targets active molecule. It exhibited potent and balanced inhibitory activities against ChE and MAO-B (huAChE, huBuChE, and huMAO-B with IC50 values of 1.2muM, 3.8muM and 2.6muM, respectively) with low selectivity. Both kinetic analysis of AChE inhibition and molecular modeling study suggested that TM-9 binds simultaneously to the catalytic active site and peripheral anionic site of AChE. Interestingly, compound TM-9 abided by Lipinski's rule of five. Furthermore, our investigation proved that TM-9 indicated weak cytotoxicity, and it could cross the blood-brain barrier (BBB) in vitro. The results suggest that compound TM-9, an interesting multi-targeted active molecule, offers an attractive starting point for further lead optimization in the drug-discovery process against Alzheimer's disease. |
| PubMedSearch : Sang_2017_Bioorg.Med.Chem.Lett_27_5053 |
| PubMedID: 29033232 |
Sang Z, Wang K, Wang H, Yu L, Ma Q, Ye M, Han X, Liu W (2017)
Design, synthesis and biological evaluation of phthalimide-alkylamine derivatives as balanced multifunctional cholinesterase and monoamine oxidase-B inhibitors for the treatment of Alzheimer's disease
Bioorganic & Medicinal Chemistry Lett
27 :5053
Sang Z, Wang K, Wang H, Yu L, Ma Q, Ye M, Han X, Liu W (2017)
Bioorganic & Medicinal Chemistry Lett
27 :5053